Back
Rapport Therapeutics, Inc. 10K Form
Sell
26
RAPP
Rapport Therapeutics, Inc.
Last Price:
$30.17
Seasonality Move:
-47.31%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RAPP News And Ratings
See the #1 stock for the next 7 days that we like better than RAPP
RAPP Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-17.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.74 |
| Price / Book: | 2.15 |
Profitability
| EPS (TTM): | -2.69250 |
|---|---|
| Net Income (TTM): | $-97.7M |
| Gross Margin: | $-839K |
| Return on Equity: | -28.91% |
| Return on Assets: | -27.62% |
Rapport Therapeutics, Inc. Earnings Forecast
Key Rapport Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 3 years have been positive in 0 years.
Rapport Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RAPP |
| Website: | rapportrx.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 36.37 |
| Quick Ratio: | 35.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RAPP Technical Analysis vs Fundamental Analysis
Sell
26
Rapport Therapeutics, Inc. (RAPP)
is a Sell
Is Rapport Therapeutics, Inc. a Buy or a Sell?
-
Rapport Therapeutics, Inc. stock is rated a SellThe current Rapport Therapeutics, Inc. [RAPP] share price is $30.20. The Score for RAPP is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.